Cargando…
A novel cuproptosis-related lncRNAs signature predicts prognostic and immune of bladder urothelial carcinoma
Bladder Urothelial Carcinoma (BLCA) remains the most common urinary system tumor, and its prognosis is poor. Cuproptosis is a recently discovered novel cell death involved in the development of tumor cells. However, the use of cuproptosis to predict the prognosis and immunity of Bladder Urothelial C...
Autores principales: | Zhou, Zheng, Zhou, Yusong, Liu, Wei, Dai, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102384/ https://www.ncbi.nlm.nih.gov/pubmed/37065485 http://dx.doi.org/10.3389/fgene.2023.1148430 |
Ejemplares similares
-
Cuproptosis-related LncRNAs signature as biomarker of prognosis and immune infiltration in pancreatic cancer
por: Chen, Hui, et al.
Publicado: (2023) -
Comprehensive analysis of cuproptosis-related lncRNAs signature to predict prognosis in bladder urothelial carcinoma
por: Zhu, Shusheng, et al.
Publicado: (2023) -
Cuproptosis-related lncRNAs predict prognosis and immune response of thyroid carcinoma
por: Shi, Yinli, et al.
Publicado: (2023) -
LncRNAs signatures associated with cuproptosis predict the prognosis of endometrial cancer
por: Qi, Shiyuan, et al.
Publicado: (2023) -
An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma
por: Chen, Xilang, et al.
Publicado: (2023)